• 1
    Galloway SM, Raetz CR. A mutant of Escherichia coli defective in the first step of endotoxin biosynthesis. J Biol Chem 1990; 265: 63946402.
  • 2
    Onishi HR, Pelak BA, Gerckens LS, Silver LL, Kahan FM, Chen MH, Patchett AA, Galloway SM, Hyland SA, Anderson MS, Raetz CR. Antibacterial agents that inhibit lipid A biosynthesis. Science 1996; 274: 980982.
  • 3
    Vaara M. Antibiotic-supersusceptible mutants of Escherichia coli and Salmonella typhimurium. Antimicrob Antimicrob Agents Chemother 1993; 37: 22552260.
  • 4
    Nikaido H. Outer membrane. In: NeidhardtFC, editor. Escherichia coli and Salmonella: Cellular and Molecular Biology, Vol. 1. Washington, DC: American Society for Microbiology; 1996. p 2947.
  • 5
    Wyckoff TJ, Raetz CR, Jackman JE. Antibacterial and anti-inflammatory agents that target endotoxin. Trends Microbiol 1998; 6: 154159.
  • 6
    Raetz CR, Roderick SL. A left-handed parallel β helix in the structure of UDP-N-acetylglucosamine acyltransferase. Science 1995; 270: 9971000.
  • 7
    Lee BI, Lee JY, Moon J, Han BW, Suh SW. Crystallization and preliminary X-ray crystallographic analysis of UDP-N-acetylglucosamine acyltransferase from Helicobacter pylori. Acta Crystallogr D 2002; 58: 864866.
  • 8
    Roujeinikova A, Baldock C, Simon WJ, Gilroy J, Baker PJ, Stuitje AR, Rice DW, Slabas AR, Rafferty JB. X-ray crystallographic studies on butyryl-ACP reveal flexibility of the structure around a putative acyl chain binding site. Structure 2002; 10: 825835.
  • 9
    Wyckoff TJ, Raetz CR. The active site of Escherichia coli UDP-N-acetylglucosamine acyltransferase: Chemical modification and site-directed mutagenesis. J Biol Chem 1999; 274: 2704727055.
  • 10
    Dotson GD, Kaltashov IA, Cotter RJ, Raetz CR. Expression cloning of a Pseudomonas gene encoding a hydroxydecanoyl-acyl carrier protein-dependent UDP-GlcNAc acyltransferase. J Bacteriol 1998; 180: 330337.